Name: BVS Income Statement - Bioventus Revenue & EPS | Ledgeburg
Creator: Ledgeburg
License: https://creativecommons.org/licenses/by/4.0/
Keywords: Revenue, Cost of Revenue, Gross Profit, Operating Expenses, Operating Income, Net Income, EPS Basic, EPS Diluted

JavaScript is disabled. Some features may not work properly. For the best experience, please enable JavaScript in your browser.

BVS - Bioventus Inc.

USD | NASDAQ | Healthcare

BVS Income Statement - Bioventus Revenue & EPS | Ledgeburg

(in millions of USD, except per-share data)	Q1 FY 26	Q4 FY 25	Q3 FY 25	Q2 FY 25	Q1 FY 25	Q4 FY 24	Q3 FY 24	Q2 FY 24	Q1 FY 24	Q3 FY 23	Q2 FY 23	Q4 FY 22	Q3 FY 22	Q2 FY 22	Q4 FY 21	Q3 FY 21	Q2 FY 21	Q4 FY 20	Q3 FY 20	Q2 FY 20	Q1 FY 20
Revenues
Revenues	132.1	157.9	138.7	147.7	123.9	153.6	139.0	151.2	129.5	120.8	119.1	128.7	140.3	117.3	108.9	109.8

Source: SEC EDGAR company filings. Figures as reported (US GAAP)

(in millions of USD, except per-share data)	TTM	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019
Revenues
Revenues	576.3	568.1	573.3	512.3	512.1	430.9	321.2	340.1
Cost of Revenue	180.4	179.9	185.1	184.2	181.0	128.2	87.6	90.9
Gross Profit	395.9	388.2	388.2	328.2	331.1	302.7	233.5	249.2
Operating Expenses
Research & Development	11.6	12.1	14.0	13.4	23.9	19.0	11.2	11.1
Selling General & Administrative	318.8	314.0	343.8	303.9
Operating Income
Operating Income	57.5	54.0	(15.2)	(81.7)	(167.2)	12.1	21.2	31.2
Non-Operating
Interest Income	-	-	-	-	-	-	-	-
Interest Expense	-	-	-	-	-	-
Tax & Net
Income Tax Expense	(0.9)	(1.6)	(5.3)	0.1	(44.4)	(2.0)	1.2	1.6
Net Income From Continuing Ops	34.5	27.3	(47.0)	(121.2)	(144.7)
Per Share
EPS Basic	0.42	0.34	(0.56)	(2.49)	(2.59)	(0.15)	-	-
EPS Diluted	0.41	0.33	(0.56)	(2.49)	(2.59)	(0.15)
Supplementary Data
EBITDA	103.9	101.0	34.4	(24.4)	(111.8)	46.9	49.9	61.5
EBIT	57.5	54.0	(15.2)	(81.7)	(167.2)	12.1

Source: SEC EDGAR company filings. Figures as reported (US GAAP)

Operating Expenses
Research & Development	2.5	3.0	2.9	3.2	3.0	3.3	3.8	4.2	2.6	3.0	3.8	4.6	6.4	6.9	6.2	4.8	0.9	2.9	3.6	2.6	2.1
Selling General & Administrative	78.3	82.8	78.7	79.1	73.5	86.9	81.5	96.7	78.8	69.8	80.9	79.0	89.6	86.1	69.6	69.1
Selling & Marketing	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
General & Administrative	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Depreciation & Amortization	11.2	32.3	1.4	1.4	11.9	33.6	2.1	2.1	11.8	2.3	16.5	2.3	2.7	12.5	1.9	1.9
Amortization of Intangibles	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Other Operating Expenses	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Operating Expenses	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

Operating Income
Operating Income	8.4	19.5	11.3	18.4	4.9	7.7	3.6	(31.5)	4.9	2.4	(92.1)	(126.8)	(3.3)	(21.5)	(1.0)	(5.7)	22.0	5.9	6.9	(4.6)	13.0

Non-Operating
Interest Income	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Interest Expense	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Income From Equity Investments	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Other Non-Operating Income	(3.9)	(5.3)	(6.6)	(8.1)	(8.3)	(7.8)	(8.9)	(10.1)	(10.4)	(10.6)	(8.1)	(3.7)	(3.2)	1.9	(2.1)	(3.3)	2.5
Pre-Tax Income	4.5	14.1	4.7	10.3	(3.4)	(0.1)	(5.3)	(41.6)	(5.5)	(8.2)	(100.2)	(130.6)	(6.5)	(19.5)	(3.2)	(9.1)

Tax & Net
Income Tax Expense	0.6	(3.2)	0.7	1.0	(0.1)	0.6	0.6	(7.3)	0.9	0.6	(0.1)	(29.5)	1.2	(5.1)	(0.9)	1.7	(0.1)	0.9	0.4	(0.1)	0.0
Net Income From Continuing Ops	3.9	17.3	4.0	9.3	(3.3)	(3.5)	(5.4)	(32.1)	(6.0)	(8.8)	(100.0)	(101.0)	(7.7)	(14.4)	(2.3)	(10.8)	24.5
Net Income From Discontinued Ops	-	-	-	-	-	0.0	0.0	0.0	0.0	0.0	(74.4)	(44.7)	(0.3)	(0.4)	-	-	-
Net Income	3.9	17.3	4.0	9.3	(3.3)	(0.6)	(5.8)	(34.2)	(6.4)	(8.8)	(174.4)	(145.7)	(8.0)	(14.8)	(2.3)	(10.8)	24.5
Net Income Attributable To Parent	3.1	14.8	3.2	7.5	(2.6)	(0.4)	(5.2)	(25.7)	(4.9)	(7.3)	(139.2)	(108.2)	(7.3)	(11.3)	(1.1)	(4.1)
Less: Minority Interest	0.8	-	0.9	1.8	(0.7)	(0.2)	(0.7)	(8.5)	(1.5)	-	-	(37.5)	(0.8)	(3.5)	(1.2)	(6.7)	(0.4)
Less: Preferred Dividends	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net Income To Common Shareholders	3.1	14.8	3.2	7.5	(2.6)	(0.4)	(5.2)	(25.7)	(4.9)	(7.3)	(139.2)	(108.2)	(7.3)	(11.3)	(1.1)

Per Share
EPS Basic	0.05	-	0.05	0.11	(0.04)	-	(0.08)	(0.40)	(0.08)	(0.12)	(2.24)	(1.76)	(0.11)	(0.19)	(0.03)	(0.10)	(0.02)	-	-	-	-
EPS Diluted	0.04	-	0.05	0.11	(0.04)	-	(0.08)	(0.40)	(0.08)	(0.12)	(2.24)	(1.76)	(0.11)	(0.19)	(0.03)	(0.10)	(0.02)	-
Shares Basic	67.3	-	66.9	66.5	66.0	-	65.3	64.1	63.4	62.8	62.1	61.7	61.5	60.5	41.8	41.8	41.8	-
Shares Diluted	70.0	-	68.8	68.5	66.0	-	65.3	64.1	63.4	62.8	62.1	61.7	61.5	60.5	41.8	41.8	41.8	-

Supplementary Data
EBITDA	19.6	51.8	12.7	19.8	16.7	41.3	5.7	(29.4)	16.7	4.7	(75.6)	(124.6)	(0.6)	(9.0)	0.8	(3.9)	29.2	23.8	8.6	(2.8)	20.3
EBIT	8.4	19.5	11.3	18.4	4.9	7.7	3.6	(31.5)	4.9	2.4	(92.1)	(126.8)	(3.3)	(21.5)	(1.0)	(5.7)	22.0	5.9	6.9